Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,189 across all filing types
Latest filing 2025-02-18 Regulatory Filings
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a newspaper advertisement of the Notice of Postal Ballot, referencing compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It mentions dispatch of the Notice of Postal Ballot dated January 30, 2025, and includes copies of the advertisement published in newspapers. The content is primarily an announcement about the dispatch and publication of the Notice of Postal Ballot, not the Notice itself or the voting results. The document is about informing the exchanges and public about the advertisement of the Notice of Postal Ballot, which is a precursor to shareholder voting. It does not contain voting results or detailed meeting materials. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA) if it contained results, but since it only announces the Notice of Postal Ballot advertisement, it is more aligned with Regulatory Filings (RNS) as a general compliance announcement. However, since the Notice of Postal Ballot is a precursor to voting and this is an announcement of the advertisement of that Notice, the best fit is Regulatory Filings (RNS). The document length is 15,000 characters, indicating it is not a brief announcement but contains detailed notices and public announcements, reinforcing it is not a report or voting result but a regulatory compliance filing.
2025-02-18 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed Notice of Postal Ballot from Strides Pharma Science Limited, dated February 17, 2025. It includes information about shareholder voting on resolutions related to the appointment of new directors, with specific dates for e-voting and result announcements. The document references compliance with SEBI Listing Regulations and the Companies Act, 2013, and provides explanatory statements for the resolutions. It is not a report of voting results, nor a proxy solicitation, but the actual notice and explanatory statement for a postal ballot seeking shareholder approval. This fits the category of Proxy Solicitation & Information Statement (PSI), as it is material sent to shareholders to provide information and request votes for meetings via postal ballot/e-voting.
2025-02-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is a transcript of an earnings call for the quarter and nine months ended December 31, 2024, for Strides Pharma Science Limited. It includes detailed management commentary on financial results, operational performance, and outlook, as well as Q&A session instructions. The text explicitly states it is a transcript of the earnings call, which is a full text transcript of a conference call discussing quarterly financial results. This matches the definition of a Call Transcript (CT). The document length is substantial (15,000 characters), and it contains detailed spoken content rather than just an announcement or summary, so it is not an Earnings Release (ER) or Report Publication Announcement (RPA). Therefore, the correct classification is CT with high confidence.
2025-02-04 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) dated January 31, 2025, regarding the publication of unaudited financial results for the quarter and nine months ended December 31, 2024. It mentions that the results were published as a newspaper advertisement and are also available on the company's website. The document includes extracts of the unaudited financial results but does not contain full financial statements or detailed analysis. The primary purpose is to inform the exchanges and public about the publication of these results in newspapers, fulfilling a regulatory disclosure requirement under SEBI LODR Regulation 47. The document length is about 13,463 characters, which is relatively short and mainly serves as an announcement of the financial results publication rather than the full interim or quarterly report itself. According to the "Menu vs Meal" rule, such a document is classified as a Report Publication Announcement (RPA) rather than an Interim/Quarterly Report (IR).
2025-01-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the availability of the audio recording of an earnings call related to the un-audited financial results for the quarter and nine months ended December 31, 2024. It references the earnings call and provides a link to the audio recording but does not contain the transcript or detailed financial data itself. The document length is short (1325 characters) and serves as an announcement rather than the full transcript. According to the classification rules, a document announcing or linking to an earnings call recording without the full transcript should be classified as a Regulatory Filing (RNS) because it does not contain the full call transcript text. Therefore, the appropriate classification is Regulatory Filings (RNS) with high confidence.
2025-01-30 English
Integrated Filing- Financial
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Integrated Filing (Financials) for the quarter and nine months ended December 31, 2024' and includes unaudited financial results for the quarter and nine months ended December 31, 2024. It references compliance with SEBI regulations and includes a Limited Review Report by auditors B S R & Co. LLP, which is typical for interim financial reporting. The document contains detailed financial data and analysis for the quarter and nine months period, including consolidated financial results and notes on accounting treatments. The presence of a Limited Review Report and detailed financial statements for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. It is not a full Annual Report (10-K), nor just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2025-01-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.